Culture, Medicine and Psychiatry

, Volume 29, Issue 4, pp 379–413 | Cite as

THE NEW PARADIGM OF RECOVERY FROM SCHIZOPHRENIA: CULTURAL CONUNDRUMS OF IMPROVEMENT WITHOUT CURE

Article

ABSTRACT.

This article is a qualitative investigation of the subjective experience of recovery from the perspective of persons living with schizophrenia-related disorders. An NIMH-sponsored ethnographic study of community outpatient clinics was completed for 90 persons taking second-generation antipsychotic medications. Research diagnostic criteria and clinical ratings were obtained in tandem with an anthropologically developed Subjective Experience of Medication Interview (SEMI) that elicits narrative data on everyday life and activities, medication and treatment, management of symptoms, expectations concerning recovery, and stigma. Ethnographic observations from diverse settings (clinics, public transportation, restaurants, homes) were also obtained. The primary findings are that recovery was experienced in relation to low levels of symptoms, the need to take medications to avoid hospitalization or psychotic episodes, and personal agency to struggle against the effects of illness. The majority of participants articulated their sense of illness recovery and expectation that their lives would improve. Improvement and recovery is an incremental, yet definitively discernable subjective process. Several problems were identified as part of this process surrounding cultural conflicts that generate the experience of ambivalence analyzed here as the “paradox of recovery without cure,” irreconcilable “catch-22” dilemmas involving sacrifice (e.g., one must be “fat” or be “crazy”), and substantial stigma despite improvement in illness and everyday life experience.

KEY WORDS:

culture recovery schizophrenia psychopharmacology atypical antipsychotics 

REFERENCES

  1. Andersson, C., M. Chakos, R. Mailman, and J. Lieberman 1998 Emerging Roles for Novel Antipsychotic Medications in the Treatment of Schizophrenia. Psychiatric Clinics of North America 21(1): 151–179.CrossRefGoogle Scholar
  2. Awad, A.G., and T.P. Hogan 1994 Subjective Response to Neuroleptics and the Quality of Life: Implications for Treatment Outcome. Acta Psychiatrica Scandinavica 89(Suppl. 380): 27–32.CrossRefGoogle Scholar
  3. Barrio, Concepcion, Ann-Marie Yamada, Hazel Atuel, Richard L. Hough, Simon Yee, Bryan Berthot, and Patricia A. Russo 2003 A Tri-ethnic Examination of Symptom Expression on the Positive and Negative Syndrome Scale in Schizophrenia Spectrum Disorders. Schizophrenia Research 60: 259–269.CrossRefGoogle Scholar
  4. Bebbington, P., and L. Kuipers 1994 The Predictive Utility of Expressed Emotion in Schizophrenia: An Aggregate Analysis. Psychological Medicine 24: 1–11Google Scholar
  5. Breier, Alan, Robert W. Buchanan, Donna Irish, and William T. Carpenter 2000 Clozapine Treatment of Outpatients with Schizophrenia: Outcome and Long- Term Response Patterns. Psychiatric Services 51(10): 1249–1253.CrossRefGoogle Scholar
  6. Budd, Richard J., Ian C. T. Hughes, and John A. Smith 1996 Health Beliefs and Compliance with Antipsychotic Medication. British Journal of Clinical Psychology 35(3): 393–397.Google Scholar
  7. Chang, Edward C. 2001 Optimism and Pessimism: Implications for Theory, Research, and Practice. Washington, D.C.: American Psychological Association.Google Scholar
  8. Davidson, Larry 2003 Living Outside Mental Illness: Qualitative Studies of Recovery in Schizophrenia. New York: New York University Press.Google Scholar
  9. Davidson, Larry, and J. S. Strauss 1992 Sense of Self in Recovery from Severe Mental Illness. British Journal of Medical Psychology 65(Pt. 2): 131–145.Google Scholar
  10. Deegan, Patricia E. 1988 Recovery: The Lived Experience of Rehabilitation. Psychosocial Rehabilitation 11(4): 11–19.Google Scholar
  11. DeSisto, M., C.M. Harding, R.V. McCormick, T. Ashikaga, and G. Brooks 1999 The Maine and Vermont Three-Decade Study of Serious Mental Illness: Longitudinal Course Comparisons. In Historical and Geographical Influences on Psychopathology. C.P. Slomkowski, ed., pp. 331–348. Mahwah, NJ: Lawrence Erlbaum Associates.Google Scholar
  12. Duckworth, Ken 1998 Awakenings with the New Antipsychotics. Psychiatric Times XV(5): 65–66.Google Scholar
  13. Duckworth, Ken, Vijaya Nair, Jayendra K. Patel, and Stephen M. Goldfinger 1997 Lost Time, Found Hope and Sorrow: The Search for Self, Connection, and Purpose During ‘Awakenings’ on the New Antipsychotics. Harvard Review of Psychiatry 5: 227–233.CrossRefGoogle Scholar
  14. Estroff, Sue 1989 Self, Identity, and Subjective Experiences of Schizophrenia: In Search of the Subject. Schizophrenia Bulletin 25: 189–196.Google Scholar
  15. First, Michael B., Robert L. Spitzer, Miriam Gibbon, and Janet B.W. Williams 2002 Structured Clinical Interview for DSM-IV-TR Axis I Disorders, Research Version, Patient Edition (SCID-I/P). New York: Biometrics Research, New York State Psychiatric Institute.Google Scholar
  16. Floersch, Jerry 2002 Meds, Money, and Manners: The Case Management of Severe Mental Illness. New York: Columbia University Press.Google Scholar
  17. Frese, F. J. 3rd 2001 Integrating Evidence-Based Practices and the Recovery Model. Psychiatric Services 52(11): 1462–1468.CrossRefGoogle Scholar
  18. Goffman, Erving 1963 Stigma: Notes on the Management of Spoiled Identity. Englewood Cliffs, NJ: Prentice-Hall.Google Scholar
  19. Goldstein, Jill M. 1988 Gender Differences in the Course of Schizophrenia. American Journal of Psychiatry 145(6): 684–689.Google Scholar
  20. Good, Byron 1977 The Heart of What's the Matter: The Semantics of Illness in Iran. Culture, Medicine and Psychiatry 1: 25–58.Google Scholar
  21.  1994 Medicine, Rationality, and Experience: An Anthropological Perspective. Cambridge: Cambridge University Press.Google Scholar
  22. Good, Mary-Jo Delvecchio, and Byron J. Good 1981 The Meaning of Symptoms: A Cultural Hermeneutic Model for Clinical Practice. In The Relevance of Social Science for Medicine. L. Eisenberg and A. Kleinman, eds., pp. 165–196. Boston: D. Reidel.Google Scholar
  23.  2000 Clinical Narratives and the Study of Contemporary Doctor-Patient Relationships. In Handbook of Social Studies in Health and Medicine. G.L. Albrecht, R. Fitzpatrick and S.C. Scrimshaw, eds., pp. 243–258. London: Sage.Google Scholar
  24. Greenhalgh, Trisha, and Brian Hurwitz 1999 Why Study Narrative? British Medical Journal 318: 48–50.Google Scholar
  25. Harrison, Glynn, Kim Hopper, Thomas Craig, Eugene Laska, Carol Siegel, Joe Wanderling, et al. 2001 Recovery from Psychotic Illness: A 15- and 25-Year International Follow-up Study. British Journal of Psychiatry 178: 506–517.CrossRefGoogle Scholar
  26. Hogan, T. P., and A. G. Awad 1992 A Self-Report Scale Predictive of Drug Compliance in Schizophrenics: A Re-examination Comparing Two Measures. Psychological Medicine 22: 347–352.CrossRefGoogle Scholar
  27. Hogarty, Gerard E., Deborah Greenwald, Richard F. Ulrich, Sander J. Kornblith, Ann Louise DiBarry, Susan Cooley, Mary Carter, Samuel Flesher 1997 Three-Year Trials of Personal Therapy among Schizophrenic Patients Living with or Independent of Family, I: Description of Study and Effects on Relapse Rates. American Journal of Psychiatry 154(11): 1504–1513.Google Scholar
  28. Holland, Dorothy, William Lachicotte, Debra Skinner, and Carole Cain 1998 Identity and Agency in Cultural Worlds. Cambridge, MA: Harvard University Press.Google Scholar
  29. Hopper, Kim 2002 When (Working) in Rome: Applying Anthropology in Caesar's Realm. Human Organization 61(3): 196–209.Google Scholar
  30.  2004 Interrogating the Meaning of “Culture” in WHO International Studies of Schizophrenia. In Schizophrenia, Culture, and Subjectivity: The Edge of Experience. J. Jenkins and R. Barrett, eds., pp. 62–86. New York: Cambridge University Press.Google Scholar
  31. Jablensky, A., Norman Sartorius, G. Ernberg, M. Anker, A. Korten, J.E. Cooper, R. Day, and A. Bertelsen 1992 Schizophrenia: Manifestations, Incidence and Course in Different Cultures—A World Health Organization Ten-Country Study. Psychological Medicine 20: 97.Google Scholar
  32. Jacobson, Nora 2001 Experiencing Recovery: A Dimensional Analysis of Recovery Narratives. Psychiatric Rehabilitation Journal 24(3): 248–256.Google Scholar
  33. Jenkins, Janis 1988a Conceptions of Schizophrenic Illness as a Problem of Nerves: A Comparative Analysis of Mexican-Americans and Anglo-Americans. Social Science and Medicine 26: 1233–1243.Google Scholar
  34.  1988b Ethnopsychiatric Interpretations of Schizophrenic Illness: The Problem of Nervios within Mexican-American Families. Culture, Medicine and Psychiatry 12: 301–329.CrossRefGoogle Scholar
  35.  1997 Subjective Experience of Persistent Schizophrenia and Depression among U.S. Latinos and Euro-Americans. British Journal of Psychiatry 171: 20–25.Google Scholar
  36.  2004 Schizophrenia as a Paradigm Case for Understanding Fundamental Human Processes. In Schizophrenia, Culture, and Subjectivity: The Edge of Experience. J. Jenkins and R. Barrett, eds., pp. 29–61. New York: Cambridge University Press.Google Scholar
  37. Jenkins, Janis, and Robert Barrett 2004 Schizophrenia, Culture, and Subjectivity: The Edge of Experience. New York: Cambridge University Press.Google Scholar
  38. Jenkins, Janis, and Elizabeth Carpenter-Song N.d. Stigma Despite Recovery: Cultural Dimensions of Schizophrenia-Related Illness in North America.Google Scholar
  39. Jenkins, Janis, and M. Karno 1992 The Meaning of ‘Expressed Emotion:’ Theoretical Issues Raised by Cross-Cultural Research. American Journal of Psychiatry 149: 9–21.Google Scholar
  40. Jenkins, Janis, and John G. Schumacher 1999 Family Burden of Schizophrenia and Depressive Illness: Specifying the Effects of Ethnicity, Gender, and Social Ecology. British Journal of Psychiatry 174: 31–38.CrossRefGoogle Scholar
  41. Jenkins, Janis, Milton E. Strauss, Elizabeth A. Carpenter, Dawn Miller, Jerry Floersch, and Martha Sajatovic 2005 Subjective Experience of Recovery from Schizophrenia-Related Disorders and Atypical Antipsychotics. International Journal of Social Psychiatry 51(3): 211–227.CrossRefGoogle Scholar
  42. Karno, Marvin, Janis H. Jenkins, Aurora de la Selva, Felipe Santana, C. Telles, and S. Lopez 1987 Expressed Emotion and Schizophrenic Outcome among Mexican-American Families. Journal of Nervous and Mental Disorders 175: 143–151.CrossRefGoogle Scholar
  43. Kleinman, Arthur 1988 The Illness Narratives: Suffering, Healing, and the Human Condition. New York: Basic Books.Google Scholar
  44.  1999 Experience and Its Moral Modes: Culture, Human Conditions, and Disorder. In The Tanner Lectures on Human Values, Vol. 20. G.B. Peterson, ed, pp. 357–420. Salt Lake City: University of Utah Press.Google Scholar
  45.  2000 The Violences of Everyday Life. In Violence and Subjectivity. V. Das, Arthur Kleinman, M. Ramphele, and P. Reynolds, eds., pp. 226–241. Berkeley: University of California Press.Google Scholar
  46. Kraepelin, E. 1919 Dementia Praecox and Paraphrenia. Edinburgh: E. and S. Livingstone.Google Scholar
  47. Leff, J., and C. Vaughn 1985 Expressed Emotion in Families. New York: Guilford Press.Google Scholar
  48. Liberman, Robert Paul, and Alex Kopelowicz 2005 Recovery from Schizophrenia: A Concept in Search of Research. Psychiatric Services 56: 735–742.CrossRefGoogle Scholar
  49. Liberman, Robert Paul, Alex Kopelowicz, Joseph Ventura, and Daniel Gutkind 2001 Operational Criteria and Factors Related to Recovery from Schizophrenia. International Review of Psychiatry 14: 256–272.Google Scholar
  50. Lieberman, Jeffrey A. 1996 Atypical Antipsychotic Drugs as a First-Line Treatment of Schizophrenia: A Rationale and Hypothesis. Journal of Clinical Psychiatry 57(Suppl. 11): 68– 71.Google Scholar
  51.  1999 Is Schizophrenia a Neurodegenerative Disorder? A Clinical and Neurobiological Perspective. Biological Psychiatry 46(6): 729–739.CrossRefGoogle Scholar
  52. Lieberman, Jeffrey A., Gary Tollefson, Mauricio Tohen, Alan I. Green, Raquel E. Gur, Rene Kahn et al. 2003 Comparative Efficacy and Safety of Atypical and Conventional Antipsychotic Drugs in First-Episode Psychosis: A Randomized, Double-Blind Trial of Olanzapine versus Haloperidol. American Journal of Psychiatry 160(8): 1396–1404.CrossRefGoogle Scholar
  53. Lin, Ming, and Arthur M. Kleinman 1988 Psychopathology and Clinical Course of Schizophrenia: A Cross-Cultural Perspective. Schizophrenia Bulletin 4: 555–567.Google Scholar
  54. Link, Bruce G., and Jo C. Phelan 2001 Conceptualizing Stigma. Annual Review of Sociology 27: 363–385.CrossRefGoogle Scholar
  55. Link, Bruce G., Elmer L. Struening, Sheree Neese-Todd, Sara Asmussen, and Jo C. Phelan 2001 Stigma as a Barrier to Recovery: The Consequences of Stigma for the Self-Esteem of People with Mental Illnesses. Psychiatric Services 52: 1620–1626.CrossRefGoogle Scholar
  56. Meddings, Sarah, and Rachel Perkins 2002 What ‘Getting Better’ Means to Staff and Users of a Rehabilitation Service: An Exploratory Study. Journal of Mental Health 11(3): 319–325.CrossRefGoogle Scholar
  57. Mueser, Kim T., Patrick W. Corrigan, David W. Hilton, Beth Tanzman, Annette Schaub, Susan Gingerich et al. 2002 Illness Management and Recovery: A Review of the Research. Psychiatric Services 53(10): 1272–1284.CrossRefGoogle Scholar
  58. National Institutes of Health 2001 Qualitative Methods in Health Research: Opportunities and Considerations in Application and Review. Bethesda, MD: NIH.Google Scholar
  59. Obeyesekere, G. 1990 The Work of Culture: Symbolic Transformation in Psychoanalysis and Anthropology. Chicago: University of Chicago Press.Google Scholar
  60. Ortner, S.B. 1996 Making Gender: The Politics and Erotics of Culture. Boston: Beacon Press.Google Scholar
  61. Ridgway, Priscilla 2001 ReStorying Psychiatric Disability: Learning from First Person Recovery Narratives. Psychiatric Rehabilitation Journal 24(4): 335–343.Google Scholar
  62. Sacks, Oliver 1990 Awakenings. New York: Harper Perennial.Google Scholar
  63. Salokangas, R.K. 1997 Living Situation, Social Network and Outcome in Schizophrenia: A Five-Year Prospective Follow-up Study. Acta Psychiatrica Scandinavica 96(6): 459–468.CrossRefGoogle Scholar
  64. Shweder, R.A. and E. Bourne 1984 Does the Concept of the Person Vary Cross-Culturally? In Culture Theory: Essays on Mind, Self, and Emotion. R.A. Shweder and R.A. LeVine, eds., pp. 158–190. New York: Cambridge University Press.Google Scholar
  65. Stahl, Stephen M. 1997 “Awakening” from Schizophrenia: Intramolecular Polypharmacy and the Atypical Antipsychotics. Journal of Clinical Psychiatry 58(9): 381–382.Google Scholar
  66. Stein, Catherine H., and Virginia Wemmerus 2001 Searching for a Normal Life: Personal Accounts of Adults with Schizophrenia, Their Parents, and Well-Siblings. Acta Psychiatrica Scandinavica 96(6): 459–68.Google Scholar
  67. Strauss, John S., and William T. Carpenter 1977 Prediction of Outcome in Schizophrenia III. Five-Year Outcome and Its Predictors. Archives of General Psychiatry 34: 159–163.Google Scholar
  68. Sullivan, Harry Stack 1962 Schizophrenia as a Human Process. New York: W. W. Norton.Google Scholar
  69. Turner, Victor 1967 The Forest of Symbols: Aspects of Ndembu Ritual. Ithaca, NY: Cornell University Press.Google Scholar
  70. Turner-Crowson, Judy, and Jan Wallcraft 2002 The Recovery Vision for Mental Health Services and Research: A British Perspective. Psychiatric Rehabilitation Journal 25(3): 245–254.Google Scholar
  71. U.S. Commission on Mental Health. See U.S. Department of Health and Human Services (USDHHS)Google Scholar
  72. U.S. Department of Health and Human Services (USDHHS) 1999 Mental Health: Report of the Surgeon General. Washington, DC: USDHHS, Office of the Surgeon General.Google Scholar
  73.  2003 Achieving the Promise: Transforming Mental Health Care in America. Executive Summary. Washington, DC: USDHHS, U.S. Commission on Mental Health.Google Scholar
  74. Vaughn, C., and J. Leff 1976 The Influence of the Family and Social Factors on the Course of Psychiatric Illness: A Comparison of Schizophrenic and Depressed Neurotic Patients. British Journal of Psychiatry 129: 125–137.Google Scholar
  75. Warner, Richard 1994 Recovery from Schizophrenia. New York: Routledge.Google Scholar
  76. Weiden, P., R. Aquila, and J. Standard 1996 Atypical Antipsychotic Drugs and Long-Term Outcome in Schizophrenia. Journal of Clinical Psychiatry 57(Suppl. 11): 53–60.Google Scholar
  77. Weiden, P., and L. Havens 1994 Psychotherapeutic Management Techniques in the Treatment of Outpatients with Schizophrenia. Hospital and Community Psychiatry 45: 549–555.Google Scholar
  78. World Health Organization 1979 Schizophrenia: An International Follow-up Study. New York: John Wiley.Google Scholar
  79.  1998 Schizophrenia and Public Health. Geneva: World Health Organization.Google Scholar
  80.  2001 The World Health Report 2001. Mental Health: New Understanding, New Hope. Geneva: World Health Organization.Google Scholar

Copyright information

© Springer Science + Business Media, Inc. 2006

Authors and Affiliations

  1. 1.Departments of Psychiatry and AnthropologyCase Western UniversityClevelandUSA
  2. 2.Department of AnthropologyCase Western UniversityClevelandUSA

Personalised recommendations